This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.


Agenus Inc.

Drug Names(s): Quilimmune-P

Description: Quilimmune-P is a vaccine designed to prevent Streptococcus pneumoniae infection in the elderly. Quilimmune-P consists of the conjugate vaccine in combination with QS-21, Antigenics' immune adjuvant designed to increase the body's immune response to a vaccine.

Quilimmune-P News

Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug